1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Sources
2.3. Research Design
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. ORGAN-ON-A-CHIP TECHNOLOGIES MARKET, BY ORGAN TYPE
5.1. Introduction
5.2. LIVER-ON-A-CHIP
5.3. HEART-ON-A-CHIP
5.4. LUNG-ON-A-CHIP
5.5. KIDNEY-ON-A-CHIP
5.6. INTESTINE-ON-A-CHIP
5.7. BRAIN-ON-A-CHIP
5.8. SKIN-ON-A-CHIP
5.9. OTHERS
6. ORGAN-ON-A-CHIP TECHNOLOGIES MARKET, BY APPLICATION
6.1. Introduction
6.2. DRUG DISCOVERY AND DEVELOPMENT
6.3. TOXICITY TESTING
6.4. DISEASE MODELING
6.5. ORGAN REGENERATION
6.6. PERSONALIZED MEDICINE
6.7. OTHERS
7. ORGAN-ON-A-CHIP TECHNOLOGIES MARKET, BY END-USER
7.1. Introduction
7.2. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
7.3. ACADEMIC AND RESEARCH INSTITUTES
7.4. CONTRACT RESEARCH ORGANIZATIONS (CROS)
7.5. OTHERS
7.6. ORGAN-ON-A-CHIP TECHNOLOGIES MARKET, BY GEOGRAPHY
7.7. Introduction
7.8. North America
7.8.1. United States
7.8.2. Canada
7.8.3. Mexico
7.9. South America
7.9.1. Brazil
7.9.2. Argentina
7.9.3. Others
7.10. Europe
7.10.1. United Kingdom
7.10.2. Germany
7.10.3. France
7.10.4. Italy
7.10.5. Spain
7.10.6. Others
7.11. Middle East and Africa
7.11.1. Saudi Arabia
7.11.2. UAE
7.11.3. Others
7.12. Asia Pacific
7.12.1. Japan
7.12.2. China
7.12.3. India
7.12.4. South Korea
7.12.5. Indonesia
7.12.6. Taiwan
7.12.7. Others
8. COMPETITIVE ENVIRONMENT AND ANALYSIS
8.1. Major Players and Strategy Analysis
8.2. Emerging Players and Market Lucrativeness
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Vendor Competitiveness Matrix
9. COMPANY PROFILES
9.1. EMULATE, INC.
9.2. TISSUSE GMBH
9.3. HESPEROS, INC.
9.4. CN BIO INNOVATIONS LTD.
9.5. AXOSIM, INC.
9.6. NORTIS, INC.
9.7. INSPHERO AG
9.8. MIMETAS B.V.
9.9. CHERRY BIOTECH
9.10. MICRONIT MICROFLUIDICS B.V.